K Number
K141789
Device Name
PLUM 360 INFUSION SYSTEM WITH HOSPIRA MEDNET, SMART CARD PLUG N PLAY CE 3.0 MODULE FOR PLUM A+ INFUSION SYSTEM UPGRADE
Manufacturer
Date Cleared
2015-01-16

(198 days)

Product Code
Regulation Number
880.5725
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Plum 360™ Infusion System with Hospira Mednet™ and Plum A+™ (360 Enabled™) Infusion System are indicated for use in parenteral, enteral and epidural therapies and the administration of whole blood products.
Device Description
The Plum 360TM Infusion System with Hospira MedNet™ remains a volumentric Infusion System intended for use in parenteral, enteral and epidural therapies and the administration of whole blood and blood products. Dedicated administration sets are used for delivery of infusion therapy to the patient. The device has a user interface consisting of LCD display, front panel numeric keypads and keys, audible and visual indicators, audible indicator volume control, nurse call interface, network interface connectors, the drug library, and software that provides pre-defined display screens for therapy programming. The continued use of the Hospira MedNet™ Software allows communication between the Infusion Pump, Hospira MedNet™ server and the facility's communication systems.
More Information

Not Found

No
The document explicitly states "Mentions AI, DNN, or ML: Not Found" and the description focuses on standard software and communication features for an infusion system.

Yes
The device is used for parenteral, enteral, and epidural therapies and the administration of whole blood products, which are all forms of medical treatment aimed at improving health, therefore it is a therapeutic device.

No
The device is an infusion system used for delivering therapies and blood products, not for diagnosing conditions.

No

The device description explicitly states it is a "volumetric Infusion System" and mentions hardware components like an LCD display, keypads, audible/visual indicators, and network interface connectors. While it includes software, it is not solely software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states the device is for "parenteral, enteral and epidural therapies and the administration of whole blood products." These are all related to delivering substances into the body, not for testing samples outside the body to diagnose conditions.
  • Device Description: The description focuses on the mechanics of an infusion system, including pumps, administration sets, user interfaces, and software for programming and communication. This aligns with a device used for administering fluids and medications, not for performing diagnostic tests on biological samples.
  • Lack of IVD Characteristics: There is no mention of analyzing biological samples (like blood, urine, tissue), reagents, or any processes typically associated with in vitro diagnostics.

Therefore, the Plum 360™ Infusion System is a therapeutic device, not an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

Plum 360™ Infusion System with Hospira Mednet™ and Plum A+™ (360 Enabled™) Infusion System are indicated for use in parenteral, enteral and epidural therapies and the administration of whole blood products.

Product codes (comma separated list FDA assigned to the subject device)

FRN, PHC, FPA

Device Description

The Plum 360TM Infusion System with Hospira MedNet™ remains a volumentric Infusion System intended for use in parenteral, enteral and epidural therapies and the administration of whole blood and blood products. Dedicated administration sets are used for delivery of infusion therapy to the patient.

The device has a user interface consisting of LCD display, front panel numeric keypads and keys, audible and visual indicators, audible indicator volume control, nurse call interface, network interface connectors, the drug library, and software that provides pre-defined display screens for therapy programming.

The continued use of the Hospira MedNet™ Software allows communication between the Infusion Pump, Hospira MedNet™ server and the facility's communication systems.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

System verification and validation activities for subject devices confirmed that the system meets and design inputs. All the testing met the acceptance criteria.

Risk management activities are incorporated in to the design and development process and safety assurance cases has been generated to demonstrate the safety of the subject devcies.

Risk management as well as verification activities incorporate the principles of applicable FDA guidance such as "Total Product Life Cycle: infusion Pump –Premarket Notification [510(k)] Submissions (DRAFT GUIDANCE)" issued in April 23, 2010 and "General Principles of Software Validation; Final Guidance for Industry and FDA Staff," issued January 11, 2002.

Human Factors studies have been conducted to validate the effectiveness of use related error mitigations.

Electrical and Mechanical Safety (ANSI/AAMI ES60601-1): PASS
Electromagnetic Compatibility (IEC 60601-1-2): PASS
Alarms System (IEC 60601-1-8): PASS
Infusion Pump Basic Safety and Essential Performance (IEC 60601-2-24): PASS
Biocompatibility (ISO 10993-1): PASS

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K042081, K982159, K052722, K061432, K101677, K103224, K103344, K113683

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 880.5725 Infusion pump.

(a)
Identification. An infusion pump is a device used in a health care facility to pump fluids into a patient in a controlled manner. The device may use a piston pump, a roller pump, or a peristaltic pump and may be powered electrically or mechanically. The device may also operate using a constant force to propel the fluid through a narrow tube which determines the flow rate. The device may include means to detect a fault condition, such as air in, or blockage of, the infusion line and to activate an alarm.(b)
Classification. Class II (performance standards).

0

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of a human figure, represented by three overlapping profiles, with the head tilted upwards.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

January 16, 2015

Hospira, Incorporated Yuliva Matlin. M.S., M.B.A. Associate Director of Global Regulatory Affairs 275 North Field Drive Lake Forest, Illinois 60045

Re: K141789

Trade/Device Name: Plum 360™ Infusion System with Hospira Mednet™, Smart Card Plug 'N Play CE 3.0 Upgrade Module for Plum A+TM Infusion System, and Plum Administration Sets Regulation Number: 21 CFR 880.5725 Regulation Name: Infusion Pump Regulatory Class: Class II

Product Code: FRN, PHC, FPA Dated: December 15, 2014 Received: December 17, 2014

Dear Ms. Malin:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

1

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely vours.

Tina Kiang -S

for Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K141789

Device Name

Plum 360 Infusion System with Hospira Mednet Smart Card Plug 'N Play CE 3.0 Upgrade Module for Plum A+ Infusion System Plum Administration Sets

Indications for Use (Describe)

Plum 360™ Infusion System with Hospira MedNet™ and Plum A+™ (360 Enabled™) Infusion System are indicated for use in parenteral, enteral and epidural therapies and the administration of whole blood products.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

_ Over-The-Counter Use (21 CFR 801 Subpart C)

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Druq Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

Image /page/3/Picture/0 description: The image shows the Hospira logo. The logo features the company name "Hospira" in a sans-serif font, with the "H" slightly larger than the other letters. Above the name is an abstract graphic consisting of three curved lines that converge at a point, creating a sense of movement or flow.

510(k) Summary of Safety and Effectiveness

K141789

Submitter Information
NameHospira, Inc.
Address275 N Field Drive, Lake Forest, IL 60045 USA
Phone Number224-212-4857
Fax Number224-212-5402
Establishment Registration Number3005579246
Name of Contact PersonYuliya Matlin, M.S., M.BA
Date PreparedJune 30, 2014
Name of Device
Trade or Proprietary NamePlum 360TM Infusion System with Hospira MedNetTM
Smart Card Plug'n' Play Module with CE 3.0 for Plum A+TM Infusion System
PlumTM Administration Sets
Common or Usual NameInfusion Pumps, Infusion safety management software &
Intravascular Administration Sets
Classification NameInfusion Pumps, Infusion safety management software &
Intravascular Administration Sets
Classification Panel80
Regulation(s)21 CFR 880.5725 & 21 CFR 880.5440
Product Code(s)FRN, PHC, FPA
Legally Marketed Device(s) To Which
Equivalence is ClaimedInfusion System:
Plum A+TM Infusion System with Hospira MednetTM (K042081)
Administration Sets:
Abbott Plum A+ Pump and Sets (K982159)
Lifeshield Latex-Free Microbore Extentsion Set, Model 14949 and
Others (K052722)
Hospira Enteral Feeding Set, Model 20640 (K061432)
Hospira Infusion Blood Sets (K101677)
Hospira Plum Infusion Set; Hospira Infusion Set with Yellow Stripe
Tubing (K103224)
Infusion Sets (K103344)
Lifeshield Vision Infusion Set with Pre-pierced Reseal (K113683)
Reason for 510(k) SubmissionIntroduction of the next generation of Plum™ Infusion System-Plum
360™ Infusion System with Hospira MedNet™ with enhanced
software, hardware and connectivity features.

Introduction of an optional Smart Card Plug 'n' Play module with
CE 3.0 for Plum A+TM Infusion System upgrade. |
| | Changes to secure lock component of Plum™ Administration Sets. |
| Device Description | The Plum 360TM Infusion System with Hospira MedNet™ remains a
volumentric Infusion System intended for use in parenteral, enteral
and epidural therapies and the administration of whole blood and
blood products. Dedicated administration sets are used for delivery of
infusion therapy to the patient.

The device has a user interface consisting of LCD display, front
panel numeric keypads and keys, audible and visual indicators,
audible indicator volume control, nurse call interface, network
interface connectors, the drug library, and software that provides pre-
defined display screens for therapy programming.

The continued use of the Hospira MedNet™ Software allows
communication between the Infusion Pump, Hospira MedNet™
server and the facility's communication systems. |
| Intended Use/Indication For Use | Plum 360™ Infusion System with Hospira Mednet™ and Plum
A+TM (360 EnabledTM) Infusion System are indicated for use in
parenteral, enteral and epidural therapies and the administration of
whole blood and blood products. |
| Summary of the Technological Characteristics of the Device Compared to the Predicate Device | |
| | Plum 360TM Infusion System with Hospira MedNet™ employs the same fundamental scientific technology, principles of
operation and intended/indications for use. In addition, the subject device includes the following notable characteristics:
• Latest CPU software version 15.0 featuring drug library enhancements, autoprogramming and alarm management
enhancments.
• Enhanced connectivity engine CE 3.0 with imporved Wi-Fi Performance, network connectivity and throughput to
Hospira MedNet™
• Enhanced hardware including egronomic enclosure, proximal tubing guides, ratcheting pole clamp and keypad.
• Enhancements to dedicated administration sets to include a modified secure lock.
• An optional Smart Card Plug 'n' Play with CE 3.0 Module allows Plum A+TM Infusion System upgrades to the |

4

Image /page/4/Picture/0 description: The image shows the Hospira logo. The logo features the company name "Hospira" in a simple, sans-serif font. Above the name is an abstract graphic consisting of three curved lines that converge at the bottom, creating a stylized, arch-like shape.

Performance Data

Summary of Non-Clinical Tests Conducted For Determination of Substantial Equivalence

Performance Test Summary - Subject Device

configuration.

System verification and validation activities for subject devices confirmed that the system meets and design inputs. All the testing met the acceptance criteria.

Risk management activities are incorporated in to the design and development process and safety assurance cases has been generated to demonstrate the safety of the subject devcies.

Risk management as well as verification activities incorporate the principles of applicable FDA guidance such as "Total Product Life Cycle: infusion Pump –Premarket Notification [510(k)] Submissions (DRAFT GUIDANCE)"

5

Image /page/5/Picture/0 description: The image shows the Hospira logo. The logo consists of the word "Hospira" in a sans-serif font, with a stylized graphic above it. The graphic is composed of three curved lines that converge at the top, resembling a stylized arch or a simplified representation of a medical device. The logo is in black and white.

Plum 360™ Infusion system with Hospira MedNet™/ Smart Card Plug 'n' Play CE 3.0 Module Traditional 510(k) Section 5: 510(k) Summary

issued in April 23, 2010 and "General Principles of Software Validation; Final Guidance for Industry and FDA Staff," issued January 11, 2002.

Human Factors studies have been conducted to validate the effectiveness of use related error mitigations.

CharacteristicsStandard/Test/FDA GuidanceResults Summary
Electrical and Mechanical
SafetyANSI/AAMI ES60601-1 Medical Electrical Equipment - Part
1: General Requirements for Basic Safety and Essential
Performance, 2005 / (R)2012 / C1:2009 / (R)2012, including
Amendment 1:2012PASS
Electromagnetic
CompatibilityIEC 60601-1-2 Medical electrical equipment - Part 1-2:
General requirements for basic safety and essential
performance - Collateral standard: Electromagnetic
compatibility - Requirements and tests, Edition 3:2007-03PASS
Alarms SystemIEC 60601-1-8 Collateral Standard: General requirements,
tests and guidance for alarm systems in medical electrical
equipment and medical electrical systems, Edition 2.0 2006-10PASS
Infusion Pump Basic Safety
and Essential PerformanceIEC 60601-2-24 Medical Electrical Equipment - Part-24:
Particular Requirements for the Basic Safety and Essential
Performance of Infusion Pump and Controllers, Edition 2.0
2012-10PASS
BiocompatibilityISO 10993-1 Biological evaluation of medical devices - Part 1:
Evaluation and testing within a risk management process,
Fourth edition 2009-10-15PASS
Summary of Clinical Tests Conducted for Determination of Substantial Equivalence and/or of Clinical Information
Clinical evaluation is not required for this submission to support substantial equivalence. Human factors studies have been
conducted on subject devcies demonstrating passing results.
Conclusion
Hospira, Inc. considers Plum 360™ Infusion System Hospira MedNet™ and Plum A+™ (360 Enabled™) Infusion System
with Hospira MedNet™ to be as safe and effective as its predicate devices. Therefore, Plum 360™ Infusion System
compatible with Hospira MedNet™ and Plum A+™ (360 Enabled™) Infusion System with Hospira MedNet™ are
substantially equivalent to predicate devices.